THE DEAL, AT A GLANCE
From the announcementNavion Neurosciences
01Who is involvedBacked by the Angelini Lumira Biosciences Fund, 3B Future Health Fund, UVA LVG Seed Fund, Virginia Innovation Partnership CorporationFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedNavion Neurosciences raised $10.8M Seed, announced 2026-09-11From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersNavion Neurosciences is using seed financing to advance preclinical precision sodium-channel therapeutics for genetic epilepsy and chronic neuropathic pain, where…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Navion Neurosciences · Financing Record
Explore source-linked visual explanations for Navion Neurosciences. Unsupported claims are withheld while source review continues.
Record 12097 · Recorded date: 2026-09-11
Explore company records →